Literature DB >> 11057739

Survival of human lung epithelial cells following in vitro alpha-particle irradiation with absolute determination of the number of alpha-particle traversals of individual cells.

C Søyland1, S P Hassfjell.   

Abstract

PURPOSE: To throw light on human exposure to domestic radon and radon progeny, the effects of low doses of alpha-particle irradiation on normal human lung epithelial cells has been studied. At such low exposure levels the concept of dose is inadequate due to the stochastic variation in the number of alpha-particle traversals per cell. The objective of the current study was to establish an accurate survival curve for human lung epithelial cells with absolute determination of the exact number of alpha-particle traversals of individual cells.
MATERIALS AND METHODS: Irradiation of L132 cells growing in tracketch detector-based cell dishes, was performed using a collimated alpha-particle beam from a 210Po source. The number of alpha-particle traversals through each individual cell was scored by using a technique of retrospective track-etch dosimetry. This technique is based upon image matching and mapping of corresponding cell and alpha-particle track images. The spatial resolution of the hit determination procedure was +/-0.9/microm.
RESULTS: Surviving fractions of cells (SF) showed strict dependence on the number of nuclear traversals (n), with SF(n)= a exp(-bn), a=0.957 (+/- 0.046), b = 0.587 (+/- 0.059), R2 =98.8%. No significant dependence on the number of nuclear membrane traversals (m) or the number of cytoplasm traversals (c) was observed.

Entities:  

Mesh:

Year:  2000        PMID: 11057739     DOI: 10.1080/09553000050151583

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  16 in total

Review 1.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

2.  Mutation induction by inhaled radon progeny modeled at the tissue level.

Authors:  Balázs G Madas; Imre Balásházy
Journal:  Radiat Environ Biophys       Date:  2011-09-06       Impact factor: 1.925

Review 3.  Molecular pathways: targeted α-particle radiation therapy.

Authors:  Kwamena E Baidoo; Kwon Yong; Martin W Brechbiel
Journal:  Clin Cancer Res       Date:  2012-12-10       Impact factor: 12.531

Review 4.  The potential complementary role of targeted alpha therapy in the management of metastatic melanoma.

Authors:  Michael P Brown; Eva Bezak; Barry J Allen
Journal:  Melanoma Manag       Date:  2015-11-24

5.  Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.

Authors:  Diane E Milenic; Kwamena E Baidoo; Young-Seung Kim; Martin W Brechbiel
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Antitumor immunity induced after α irradiation.

Authors:  Jean-Baptiste Gorin; Jérémie Ménager; Sébastien Gouard; Catherine Maurel; Yannick Guilloux; Alain Faivre-Chauvet; Alfred Morgenstern; Frank Bruchertseifer; Michel Chérel; François Davodeau; Joëlle Gaschet
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

Review 7.  α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1.

Authors:  Sophie Poty; Lynn C Francesconi; Michael R McDevitt; Michael J Morris; Jason S Lewis
Journal:  J Nucl Med       Date:  2018-03-15       Impact factor: 10.057

8.  (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.

Authors:  Kwon Joong Yong; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  Mol Cancer Ther       Date:  2012-01-11       Impact factor: 6.261

9.  Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

Authors:  Kwon Yong; Martin W Brechbiel
Journal:  Dalton Trans       Date:  2011-03-04       Impact factor: 4.390

10.  Effects of radiation type and delivery mode on a radioresistant eukaryote Cryptococcus neoformans.

Authors:  Igor Shuryak; Ruth A Bryan; Jack Broitman; Stephen A Marino; Alfred Morgenstern; Christos Apostolidis; Ekaterina Dadachova
Journal:  Nucl Med Biol       Date:  2015-03-11       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.